AIM:ANCR

Stock Analysis Report

Executive Summary

Animalcare Group plc engages in the development, sale, and distribution of licensed veterinary pharmaceuticals; and identification products and services to companion animal veterinary markets in Europe, Asia, the Middle East, Africa, and internationally.


Snowflake Analysis

Fair value with mediocre balance sheet.

Share Price & News

How has Animalcare Group's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: ANCR's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

0%

ANCR

-0.3%

GB Healthcare

10.0%

GB Market


1 Year Return

32.6%

ANCR

-32.6%

GB Healthcare

-23.0%

GB Market

Return vs Industry: ANCR exceeded the UK Healthcare industry which returned -32.6% over the past year.

Return vs Market: ANCR exceeded the UK Market which returned -23% over the past year.


Shareholder returns

ANCRIndustryMarket
7 Day0%-0.3%10.0%
30 Day-21.2%-17.8%-17.6%
90 Day-12.9%-36.3%-27.3%
1 Year36.3%32.6%-31.5%-32.6%-18.9%-23.0%
3 Yearn/a-46.7%-49.0%-12.9%-24.2%
5 Yearn/a-12.2%-16.8%1.6%-21.8%

Price Volatility Vs. Market

How volatile is Animalcare Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Animalcare Group undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: ANCR (£1.53) is trading below our estimate of fair value (£6.41)

Significantly Below Fair Value: ANCR is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: ANCR is unprofitable, so we can't compare its PE Ratio to the Healthcare industry average.

PE vs Market: ANCR is unprofitable, so we can't compare its PE Ratio to the UK market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate ANCR's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: ANCR is good value based on its PB Ratio (1.1x) compared to the GB Healthcare industry average (1.2x).


Next Steps

Future Growth

How is Animalcare Group forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

2.8%

Forecasted annual revenue growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if ANCR's forecast earnings growth is above the savings rate (0.5%).

Earnings vs Market: Insufficient data to determine if ANCR's earnings are forecast to grow faster than the UK market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: ANCR's revenue (2.8% per year) is forecast to grow faster than the UK market (2.3% per year).

High Growth Revenue: ANCR's revenue (2.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if ANCR's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Animalcare Group performed over the past 5 years?

-57.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ANCR is currently unprofitable.

Growing Profit Margin: ANCR is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: ANCR is unprofitable, and losses have increased over the past 5 years at a rate of -57% per year.

Accelerating Growth: Unable to compare ANCR's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ANCR is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (19.8%).


Return on Equity

High ROE: ANCR has a negative Return on Equity (-3%), as it is currently unprofitable.


Next Steps

Financial Health

How is Animalcare Group's financial position?


Financial Position Analysis

Short Term Liabilities: ANCR's short term assets (£32.1M) exceed its short term liabilities (£18.4M).

Long Term Liabilities: ANCR's short term assets (£32.1M) exceed its long term liabilities (£31.6M).


Debt to Equity History and Analysis

Debt Level: ANCR's debt to equity ratio (29.2%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if ANCR's debt to equity ratio has reduced over the past 5 years.


Balance Sheet

Inventory Level: ANCR has a low level of unsold assets or inventory.

Debt Coverage by Assets: ANCR's debt is covered by short term assets (assets are 1.3x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if ANCR has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if ANCR has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is Animalcare Group's current dividend yield, its reliability and sustainability?

2.89%

Forecast Dividend Yield


Dividend Yield vs Market

Notable Dividend: Unable to evaluate ANCR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate ANCR's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ANCR's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ANCR's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: ANCR is not paying a notable dividend for the UK market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ANCR's dividend in 3 years as they are not forecast to pay a notable one for the UK market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.4yrs

Average management tenure


CEO

Jenny Winter (59yo)

1.42s

Tenure

UK£287,000

Compensation

Ms. Jennifer Ann Julia Winter, also known as Jenny, BSc serves as Chief Executive Officer at Animalcare Group plc since October 01, 2018 and its Director at October 1, 2018. She served as Vice President of ...


CEO Compensation Analysis

Compensation vs Market: Jenny's total compensation ($USD356.24K) is about average for companies of similar size in the UK market ($USD335.89K).

Compensation vs Earnings: Insufficient data to compare Jenny's compensation with company performance.


Leadership Team

NamePositionTenureCompensationOwnership
Jennifer Ann Winter
CEO & Director1.42yrsUK£287.00kno data
Christopher Brewster
CFO, Company Secretary & Director3.17yrsUK£242.00k0.47% £427.8k
Jeroen Bastijns
Head of Business Development2.67yrsno datano data
Emilio Ventura
Head of Strategy & Country Manager of Spanish Business2.67yrsno datano data
Stephen Pearson
Group Head of Supply Chain2.17yrsno datano data
Martin Gore
Head of Commercialno datano datano data

2.4yrs

Average Tenure

Experienced Management: ANCR's management team is considered experienced (2.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Jennifer Ann Winter
CEO & Director1.42yrsUK£287.00kno data
Christopher Brewster
CFO, Company Secretary & Director3.17yrsUK£242.00k0.47% £427.8k
Marc Armand Alice André Coucke
Non-Executive Director2.67yrsUK£40.00kno data
Edwin T. Torr
Senior Independent Non Executive Director2.67yrsUK£40.00k0.18% £163.9k
Jan Marcel Matthieu Boone
Non-Executive Chairman2.67yrsUK£70.00k0.084% £76.5k
Nick Downshire
Independent Non-Executive Director12.17yrsUK£40.00k1.72% £1.6m
Christiaan Cardon
Non-Executive Directorno dataUK£386.00kno data

2.7yrs

Average Tenure

54yo

Average Age

Experienced Board: ANCR's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Animalcare Group plc's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Animalcare Group plc
  • Ticker: ANCR
  • Exchange: AIM
  • Founded: 1972
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Market Cap: UK£91.587m
  • Shares outstanding: 60.06m
  • Website: https://www.animalcaregroup.co.uk

Number of Employees


Location

  • Animalcare Group plc
  • Unit 7, York Business Park
  • 10 Great North Way
  • York
  • North Yorkshire
  • YO26 6RB
  • United Kingdom

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ANCRAIM (London Stock Exchange AIM Market)YesOrdinary Nominative SharesGBGBPJul 2017

Biography

Animalcare Group plc engages in the development, sale, and distribution of licensed veterinary pharmaceuticals; and identification products and services to companion animal veterinary markets in Europe, Asia, the Middle East, Africa, and internationally. It is also involved in the marketing of veterinary pharmaceuticals. The company was founded in 1972 and is based in York, the United Kingdom. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/03/31 00:23
End of Day Share Price2020/03/30 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.